Immunogenicity 12095
Sample ID
3903
Response
Negative
Tumor Type
Melanoma
Gene Symbol
OR51G2
Transcript ID
uc001lzr.1
HLA INFO
B*38:01
TCR INFO
No TCR info found!
Full length protein sequence (314 aa)
MTLGS
1
LGNSS
6
SSVSA
11
TFLLS
16
GIPGL
21
ERMHI
26
WISIP
31
LCFMY
36
LVSIP
41
GNCTI
46
LFIIK
51
TERSL
56
HEPMY
61
LFLSM
66
LALID
71
LGLSL
76
CTLPT
81
VLGIF
86
WVGAR
91
EISHD
96
ACFAQ
101
LFFIH
106
CFSFL
111
ESSVL
116
LSMAF
121
DRFVA
126
ICHPL
131
HYVSI
136
LTNTV
141
IGRIG
146
LVSLG
151
RSVAL
156
IFPLP
161
FMLKR
166
FPYCG
171
SPVLS
176
HSYCL
181
HQEVM
186
KLACA
191
DMKAN
196
SIYGM
201
FVIVS
206
TVGID
211
SLLIL
216
FSYAL
221
ILRTV
226
LSIAS
231
RAERF
236
KALNT
241
CVSHI
246
CAVLL
251
FYTPM
256
IGLSV
261
IHRFG
266
KQAPH
271
LVQVV
276
MGFMY
281
LLFPP
286
VMNPI
291
VYSVK
296
TKQIR
301
DRVTH
306
AFCY
311
Mutation Information
DNA mutation:
None
Peptide Range:
103 ~ 127
Mut AA position:
115 (13 in Wild Type peptide)
Alignment
Wild Type:
"FAQLFFIHCFSFLESSVLLSMAFDR
||||||||||||.||||||||||||
Mutant:
FAQLFFIHCFSFFESSVLLSMAFDR"
Nat Med, 2016
Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patientsGene Name (from Reference) OR51G2
Checkpoint
Blockade
None
ACT
None
Vaccination
None
Curative
Effect
None
minimal_peptide
None
Antigen
Type
TMG RNA
T-cell
Source
PBMCs
APC
Type
autologous DCs
Assay
IFNg ELISPOT assay